logo
How it worksCoursesResearch CommunitiesBenefitsAbout Us
Schedule Demo
Learn Before
Relation

Biomedical Engineering for COVID-19 Articles from the Lancet Journal

  • Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

  • Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

  • Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

  • Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

0

1

Updated 2020-10-24

Contributors are:

Yeji Lee
Yeji Lee
🏆 2

LW

Lauren Waters
✔️ 1.5
Emily Mackey
Emily Mackey
✔️ 1
Sai Tummala
Sai Tummala
✔️ 1
Breona Martin
Breona Martin
✔️ 0.5
Junyang (Noel) Li
Junyang (Noel) Li
✔️ 0.5

Who are from:

Smith College
Smith College
🏆 3
Bowdoin College
Bowdoin College
✔️ 1.5
University of California, Santa Cruz
University of California, Santa Cruz
✔️ 1
Lebanon Valley College
Lebanon Valley College
✔️ 1

Tags

SARS-CoV-2 (COVID-19)

Biomedical Sciences

Related
Learn After